GlassScriptPhysician profile
Neal E Ipema
NPI 1659693679
$1,821.59
in general payments reported to CMS, 2019-2025
24 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $41.66 · 2022: $365 · 2023: $514 · 2024: $191 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $319.14 | 2019-2024 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $271.31 | 2019-2025 | |
| Abbvie INC. | $227.68 | 2019-2023 | |
| Coopersurgical, INC. | $215.41 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $136.81 | 2019-2025 | |
| Astellas Pharma US INC | $93.79 | 2023-2025 | Veozah |
| Medtronic, INC. | $72.83 | 2022 | |
| Exeltis, USA INC. | $60.28 | 2020-2024 | Slynd |
| Mayne Pharma Commercial LLC | $50.92 | 2022-2023 | |
| Boston Scientific Corporation | $49.68 | 2019 | |
| Meditrina | $47.65 | 2023-2024 | |
| Allergan, INC. | $44.08 | 2019 | |
| Millicent US INC | $33.96 | 2025 | Intrarosa, Femlyv |
| Avanos Medical | $28.11 | 2019 | |
| Therapeuticsmd, INC. | $27.40 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $23.99 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.21 | 2019 | |
| Sumitomo Pharma America, INC. | $16.23 | 2023 | Myfembree |
| Exact Sciences Corporation | $15.64 | 2025 | The Cologuard Plus Collection Kit |
| Alexion Pharmaceuticals, INC. | $14.51 | 2019 | |
| Covidien LP | $14.22 | 2020 | |
| Shield Therapeutics INC | $13.66 | 2023 | Accrufer |
| Duchesnay USA Incorporated | $12.78 | 2019 | |
| Lupin INC. | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Ipema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.